Ownership history in Squarepoint Ops LLC Β· 9 quarters on record
This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in BOLT BIOTHERAPEUTICS INC (BOLT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Squarepoint Ops LLC underperformed the S&P 500 by β112.4% annually on this BOLT position. Timing score: 50% (4/8 decisions correct). Average cost basis: $28.01. Maximum drawdown during holding period: β94.6%.
β Significantly underperformed the S&P 500 by 112.4% ann.
8 quarters analyzed
β‘οΈ Neutral timing β roughly coin-flip accuracy on add/trim calls.
4 of 8 add/trim decisions correct
Best entry: $5.32 (2025 Q3) Β· Worst: $98.00 (2021 Q4)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
5 adds Β· 4 trims. Bought during 4 of 6 down-price quarters. π More buys than sells across the holding period.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.0% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size